evobrutinib
merck
['evobrutinib']
#ectrims2022: dose-dependent reductions in nfl were observed at week 144 in both those who continued on #evobrutinib from the double-blind period and those who switched from placebo. for more: 
Managing editor, @Neurology_Live ??  host #MindMoments podcast ?? host @medicalwrldnews Deep Dive ?? ??:mhoffman(at)neurologylive(dot)com